Treatment of rhabdomyosarcoma in children and adolescent from four low health expenditures average rates countries

Abstract

Survival of children with cancer in Eastern and Central Europe is 10–20% lower than in high income European countries. We evaluated outcome of children and adolescents with rhabdomyosarcoma (RMS) in Slovenia, Croatia, Slovakia and in Romania.

Keywords

• rhabdomyosarcoma
• low income country
• outcome